April - 2011
| Previous Next | Showing Journal 5 of 21 |
Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label IndicationsVeronica Yank, MD; C. Vaughan Tuohy, BS; Aaron C. Logan, MD, PhD et al Annals of Internal Medicine, 2011, 154 : 529-540 This page is only available to Crit-IQ subscribers. To view the rest of this review and gain access to our vast array of critical care teaching tools including podcasts, vodcasts, modules, exam preparation tools, teaching aids and much more, login here, or Become a Member to register |
April |
Previous Comments
No Comments yet.
Comment
"And Factor 7 goes down, blood gushing from a cut above the eye. Can it get back to its feet? Tranexamic acid is stalking its opponent, waiting for the kill. How much longer can this go on....."